Literature DB >> 23873937

Does the microenvironment influence the cell types of origin for prostate cancer?

Andrew S Goldstein1, Owen N Witte.   

Abstract

Despite several recent studies addressing the cells of origin for prostate cancer, there is still considerable discussion in the field regarding the most relevant target populations for transformation. Tissue regeneration studies have pointed to a basal cell origin for mouse and human prostate cancer. In contrast, genetically engineered mouse models demonstrate that cells within both the basal and luminal layers can initiate murine prostate cancer. Based on differences between these two approaches, we propose that further work should address the requirement for microenvironmental components such as immune or mesenchymal cells on epithelial cell types of origin for prostate cancer.

Entities:  

Keywords:  cell of origin; inflammation; prostate cancer

Mesh:

Year:  2013        PMID: 23873937      PMCID: PMC3731542          DOI: 10.1101/gad.222380.113

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  64 in total

1.  A tale of two cells: discovering the origin of prostate cancer.

Authors:  Ken Garber
Journal:  J Natl Cancer Inst       Date:  2010-10-08       Impact factor: 13.506

2.  Pten deletion leads to the expansion of a prostatic stem/progenitor cell subpopulation and tumor initiation.

Authors:  Shunyou Wang; Alejandro J Garcia; Michelle Wu; Devon A Lawson; Owen N Witte; Hong Wu
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-23       Impact factor: 11.205

3.  Cell of origin strongly influences genetic selection in a mouse model of T-ALL.

Authors:  Katherine E Berquam-Vrieze; Kishore Nannapaneni; Benjamin T Brett; Linda Holmfeldt; Jing Ma; Oksana Zagorodna; Nancy A Jenkins; Neal G Copeland; David K Meyerholz; C Michael Knudson; Charles G Mullighan; Todd E Scheetz; Adam J Dupuy
Journal:  Blood       Date:  2011-08-09       Impact factor: 22.113

4.  Targeted oncogene activation by site-specific recombination in transgenic mice.

Authors:  M Lakso; B Sauer; B Mosinger; E J Lee; R W Manning; S H Yu; K L Mulder; H Westphal
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-15       Impact factor: 11.205

5.  Sox2 cooperates with inflammation-mediated Stat3 activation in the malignant transformation of foregut basal progenitor cells.

Authors:  Kuancan Liu; Ming Jiang; Yun Lu; Hao Chen; Jun Sun; Shaoping Wu; Wei-Yao Ku; Hiroshi Nakagawa; Yoshiaki Kita; Shoji Natsugoe; Jeffrey H Peters; Anil Rustgi; Mark W Onaitis; Amy Kiernan; Xiaoxin Chen; Jianwen Que
Journal:  Cell Stem Cell       Date:  2013-03-07       Impact factor: 24.633

6.  Nkx3.1; Pten mutant mice develop invasive prostate adenocarcinoma and lymph node metastases.

Authors:  Cory Abate-Shen; Whitney A Banach-Petrosky; Xiaohui Sun; Kyriakos D Economides; Nishita Desai; Jeffery P Gregg; Alexander D Borowsky; Robert D Cardiff; Michael M Shen
Journal:  Cancer Res       Date:  2003-07-15       Impact factor: 12.701

7.  Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer.

Authors:  Shunyou Wang; Jing Gao; Qunying Lei; Nora Rozengurt; Colin Pritchard; Jing Jiao; George V Thomas; Gang Li; Pradip Roy-Burman; Peter S Nelson; Xin Liu; Hong Wu
Journal:  Cancer Cell       Date:  2003-09       Impact factor: 31.743

8.  In vivo regeneration of murine prostate from dissociated cell populations of postnatal epithelia and urogenital sinus mesenchyme.

Authors:  Li Xin; Hisamitsu Ide; Yoon Kim; Purnima Dubey; Owen N Witte
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-08       Impact factor: 11.205

9.  Association of the innate immunity and inflammation pathway with advanced prostate cancer risk.

Authors:  Rémi Kazma; Joel A Mefford; Iona Cheng; Sarah J Plummer; Albert M Levin; Benjamin A Rybicki; Graham Casey; John S Witte
Journal:  PLoS One       Date:  2012-12-14       Impact factor: 3.240

10.  The genomic complexity of primary human prostate cancer.

Authors:  Michael F Berger; Michael S Lawrence; Francesca Demichelis; Yotam Drier; Kristian Cibulskis; Andrey Y Sivachenko; Andrea Sboner; Raquel Esgueva; Dorothee Pflueger; Carrie Sougnez; Robert Onofrio; Scott L Carter; Kyung Park; Lukas Habegger; Lauren Ambrogio; Timothy Fennell; Melissa Parkin; Gordon Saksena; Douglas Voet; Alex H Ramos; Trevor J Pugh; Jane Wilkinson; Sheila Fisher; Wendy Winckler; Scott Mahan; Kristin Ardlie; Jennifer Baldwin; Jonathan W Simons; Naoki Kitabayashi; Theresa Y MacDonald; Philip W Kantoff; Lynda Chin; Stacey B Gabriel; Mark B Gerstein; Todd R Golub; Matthew Meyerson; Ashutosh Tewari; Eric S Lander; Gad Getz; Mark A Rubin; Levi A Garraway
Journal:  Nature       Date:  2011-02-10       Impact factor: 49.962

View more
  20 in total

1.  Advanced neuroendocrine prostate tumors regress to stemness.

Authors:  Leigh Ellis; Massimo Loda
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-17       Impact factor: 11.205

2.  v-Src Oncogene Induces Trop2 Proteolytic Activation via Cyclin D1.

Authors:  Xiaoming Ju; Xuanmao Jiao; Adam Ertel; Mathew C Casimiro; Gabriele Di Sante; Shengqiong Deng; Zhiping Li; Agnese Di Rocco; Tingting Zhan; Adam Hawkins; Tanya Stoyanova; Sebastiano Andò; Alessandro Fatatis; Michael P Lisanti; Leonard G Gomella; Lucia R Languino; Richard G Pestell
Journal:  Cancer Res       Date:  2016-09-15       Impact factor: 12.701

3.  Distinct phases of human prostate cancer initiation and progression can be driven by different cell-types.

Authors:  Tanya Stoyanova; Andrew S Goldstein
Journal:  Cancer Cell Microenviron       Date:  2014

Review 4.  Prostate epithelial stem and progenitor cells.

Authors:  Oh-Joon Kwon; Li Xin
Journal:  Am J Clin Exp Urol       Date:  2014-10-02

5.  Inflammation promotes prostate differentiation.

Authors:  Xian Liu; Andrew S Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-23       Impact factor: 11.205

Review 6.  Inflammation and prostate cancer: friends or foe?

Authors:  Gianluigi Taverna; Elisa Pedretti; Giuseppe Di Caro; Elena Monica Borroni; Federica Marchesi; Fabio Grizzi
Journal:  Inflamm Res       Date:  2015-03-19       Impact factor: 4.575

7.  Cancer stem cells: constantly evolving and functionally heterogeneous therapeutic targets.

Authors:  Tao Yang; Kiera Rycaj; Zhong-Min Liu; Dean G Tang
Journal:  Cancer Res       Date:  2014-04-08       Impact factor: 12.701

8.  Luminal cells are favored as the cell of origin for prostate cancer.

Authors:  Zhu A Wang; Roxanne Toivanen; Sarah K Bergren; Pierre Chambon; Michael M Shen
Journal:  Cell Rep       Date:  2014-08-28       Impact factor: 9.423

Review 9.  The many ways to make a luminal cell and a prostate cancer cell.

Authors:  Douglas W Strand; Andrew S Goldstein
Journal:  Endocr Relat Cancer       Date:  2015-08-25       Impact factor: 5.678

10.  Tumor-suppressive activity of Lunatic Fringe in prostate through differential modulation of Notch receptor activation.

Authors:  Shubing Zhang; Wen-cheng Chung; Guanming Wu; Sean E Egan; Keli Xu
Journal:  Neoplasia       Date:  2014-02       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.